Sternini C, Spann M, Anton B, Keith D E, Bunnett N W, von Zastrow M, Evans C, Brecha N C
CURE Digestive Diseases Research Center, West Los Angeles Veterans Administration Medical Center, CA 90073, USA.
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9241-6. doi: 10.1073/pnas.93.17.9241.
Opiate alkaloids are potent analgesics that exert multiple pharmacological effects in the nervous system by activating G protein-coupled receptors. Receptor internalization upon stimulation may be important for desensitization and resensitization, which affect cellular responsiveness to ligands. Here, we investigated the agonist-induced internalization of the mu opioid receptor (MOR) in vivo by using the guinea pig ileum as a model system and immunohistochemistry with an affinity-purified antibody to the C terminus of rat MOR. Antibody specificity was confirmed by the positive staining of human embryonic kidney 293 cells transfected with epitope-tagged MOR cDNA, by the lack of staining of cells transfected with the delta or kappa receptor cDNA, and by the abolition of staining when the MOR antibody was preadsorbed with the MOR peptide fragment. Abundant MOR immunoreactivity (MOR-IR) was localized to the cell body, dendrites, and axonal processes of myenteric neurons. Immunostaining was primarily confined to the plasma membrane of cell bodies and processes. Within 15 min of an intraperitoneal injection of the opiate agonist etorphine, intense MOR-IR was present in vesicle-like structures, which were identified as endosomes by confocal microscopy. At 30 min, MOR-IR was throughout the cytoplasm and in perinuclear vesicles. MOR-IR was still internalized at 120 min. Agonist-induced endocytosis was completely inhibited by the opiate antagonist naloxone. Interestingly, morphine, a high-affinity MOR agonist, did not cause detectable internalization, but it partially inhibited the etorphine-induced MOR endocytosis. These results demonstrate the occurrence of agonist-selective MOR endocytosis in neurons naturally expressing this receptor in vivo and suggest the existence of different mechanisms regulating cellular responsiveness to ligands.
阿片生物碱是强效镇痛药,通过激活G蛋白偶联受体在神经系统中发挥多种药理作用。刺激后受体的内化对于脱敏和再敏化可能很重要,这会影响细胞对配体的反应性。在这里,我们以豚鼠回肠为模型系统,并使用针对大鼠MOR C末端的亲和纯化抗体进行免疫组织化学,研究了体内阿片受体激动剂诱导的μ阿片受体(MOR)内化。通过用表位标签的MOR cDNA转染的人胚肾293细胞的阳性染色、用δ或κ受体cDNA转染的细胞缺乏染色以及当MOR抗体与MOR肽片段预吸附时染色的消除,证实了抗体的特异性。丰富的MOR免疫反应性(MOR-IR)定位于肌间神经元的细胞体、树突和轴突过程。免疫染色主要局限于细胞体和突起的质膜。腹腔注射阿片激动剂埃托啡后15分钟内,强烈的MOR-IR出现在囊泡样结构中,通过共聚焦显微镜鉴定为内体。30分钟时,MOR-IR遍布细胞质和核周囊泡。120分钟时MOR-IR仍在发生内化。阿片拮抗剂纳洛酮完全抑制了激动剂诱导的内吞作用。有趣的是,高亲和力MOR激动剂吗啡并未引起可检测到的内化,但它部分抑制了埃托啡诱导的MOR内吞作用。这些结果证明了在体内天然表达该受体的神经元中存在激动剂选择性的MOR内吞作用,并提示存在调节细胞对配体反应性的不同机制。